255 related articles for article (PubMed ID: 10818225)
21. TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5).
Kashiwagi M; Tortorella M; Nagase H; Brew K
J Biol Chem; 2001 Apr; 276(16):12501-4. PubMed ID: 11278243
[TBL] [Abstract][Full Text] [Related]
22. TIMP-3 inhibits the procollagen N-proteinase ADAMTS-2.
Wang WM; Ge G; Lim NH; Nagase H; Greenspan DS
Biochem J; 2006 Sep; 398(3):515-9. PubMed ID: 16771712
[TBL] [Abstract][Full Text] [Related]
23. Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice.
Kassiri Z; Oudit GY; Sanchez O; Dawood F; Mohammed FF; Nuttall RK; Edwards DR; Liu PP; Backx PH; Khokha R
Circ Res; 2005 Aug; 97(4):380-90. PubMed ID: 16037568
[TBL] [Abstract][Full Text] [Related]
24. Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease.
Lammich S; Kojro E; Postina R; Gilbert S; Pfeiffer R; Jasionowski M; Haass C; Fahrenholz F
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3922-7. PubMed ID: 10097139
[TBL] [Abstract][Full Text] [Related]
25. Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration.
Murai T; Miyazaki Y; Nishinakamura H; Sugahara KN; Miyauchi T; Sako Y; Yanagida T; Miyasaka M
J Biol Chem; 2004 Feb; 279(6):4541-50. PubMed ID: 14623895
[TBL] [Abstract][Full Text] [Related]
26. Constitutive shedding of the amyloid precursor protein ectodomain is up-regulated by tumour necrosis factor-alpha converting enzyme.
Slack BE; Ma LK; Seah CC
Biochem J; 2001 Aug; 357(Pt 3):787-94. PubMed ID: 11463349
[TBL] [Abstract][Full Text] [Related]
27. Purification of ADAM 10 from bovine spleen as a TNFalpha convertase.
Lunn CA; Fan X; Dalie B; Miller K; Zavodny PJ; Narula SK; Lundell D
FEBS Lett; 1997 Jan; 400(3):333-5. PubMed ID: 9009225
[TBL] [Abstract][Full Text] [Related]
28. Catalytic properties of ADAM12 and its domain deletion mutants.
Jacobsen J; Visse R; Sørensen HP; Enghild JJ; Brew K; Wewer UM; Nagase H
Biochemistry; 2008 Jan; 47(2):537-47. PubMed ID: 18081311
[TBL] [Abstract][Full Text] [Related]
29. Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2).
Kveiborg M; Jacobsen J; Lee MH; Nagase H; Wewer UM; Murphy G
Biochem J; 2010 Aug; 430(1):79-86. PubMed ID: 20533908
[TBL] [Abstract][Full Text] [Related]
30. Epithelial and bacterial metalloproteinases and their inhibitors in H. pylori infection of human gastric cells.
Göõz M; Göõz P; Smolka AJ
Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G823-32. PubMed ID: 11518695
[TBL] [Abstract][Full Text] [Related]
31. Engineering N-terminal domain of tissue inhibitor of metalloproteinase (TIMP)-3 to be a better inhibitor against tumour necrosis factor-alpha-converting enzyme.
Lee MH; Verma V; Maskos K; Nath D; Knäuper V; Dodds P; Amour A; Murphy G
Biochem J; 2002 May; 364(Pt 1):227-34. PubMed ID: 11988096
[TBL] [Abstract][Full Text] [Related]
32. The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs.
Amour A; Knight CG; English WR; Webster A; Slocombe PM; Knäuper V; Docherty AJ; Becherer JD; Blobel CP; Murphy G
FEBS Lett; 2002 Jul; 524(1-3):154-8. PubMed ID: 12135759
[TBL] [Abstract][Full Text] [Related]
33. Ectodomain shedding of TNF-alpha is enhanced by nardilysin via activation of ADAM proteases.
Hiraoka Y; Yoshida K; Ohno M; Matsuoka T; Kita T; Nishi E
Biochem Biophys Res Commun; 2008 May; 370(1):154-8. PubMed ID: 18355445
[TBL] [Abstract][Full Text] [Related]
34. Altered processing of the amyloid precursor protein and decreased expression of ADAM 10 by chronic hypoxia in SH-SY5Y: no role for the stress-activated JNK and p38 signalling pathways.
Webster NJ; Green KN; Settle VJ; Peers C; Vaughan PF
Brain Res Mol Brain Res; 2004 Nov; 130(1-2):161-9. PubMed ID: 15519686
[TBL] [Abstract][Full Text] [Related]
35. The secretases that cleave angiotensin converting enzyme and the amyloid precursor protein are distinct from tumour necrosis factor-alpha convertase.
Parvathy S; Karran EH; Turner AJ; Hooper NM
FEBS Lett; 1998 Jul; 431(1):63-5. PubMed ID: 9684866
[TBL] [Abstract][Full Text] [Related]
36. Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling.
Kopitz C; Gerg M; Bandapalli OR; Ister D; Pennington CJ; Hauser S; Flechsig C; Krell HW; Antolovic D; Brew K; Nagase H; Stangl M; von Weyhern CW; Brücher BL; Brand K; Coussens LM; Edwards DR; Krüger A
Cancer Res; 2007 Sep; 67(18):8615-23. PubMed ID: 17875701
[TBL] [Abstract][Full Text] [Related]
37. Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells from extrinsic cell death: a potential oncogenic activity of tissue inhibitor of metalloproteinase-1.
Liu XW; Taube ME; Jung KK; Dong Z; Lee YJ; Roshy S; Sloane BF; Fridman R; Kim HR
Cancer Res; 2005 Feb; 65(3):898-906. PubMed ID: 15705888
[TBL] [Abstract][Full Text] [Related]
38. Morbillivirus infection of the mouse central nervous system induces region-specific upregulation of MMPs and TIMPs correlated to inflammatory cytokine expression.
Khuth ST; Akaoka H; Pagenstecher A; Verlaeten O; Belin MF; Giraudon P; Bernard A
J Virol; 2001 Sep; 75(17):8268-82. PubMed ID: 11483772
[TBL] [Abstract][Full Text] [Related]
39. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10.
Abel S; Hundhausen C; Mentlein R; Schulte A; Berkhout TA; Broadway N; Hartmann D; Sedlacek R; Dietrich S; Muetze B; Schuster B; Kallen KJ; Saftig P; Rose-John S; Ludwig A
J Immunol; 2004 May; 172(10):6362-72. PubMed ID: 15128827
[TBL] [Abstract][Full Text] [Related]
40. Modeling of enzyme-substrate complexes for the metalloproteases MMP-3, ADAM-9 and ADAM-10.
Manzetti S; McCulloch DR; Herington AC; van der Spoel D
J Comput Aided Mol Des; 2003 Sep; 17(9):551-65. PubMed ID: 14713188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
